You are here

GSK

GSK, Bayer stand by CureVac following 'disappointing' COVID-19 vaccine trial flop

Fierce Pharma

Thu, 06/17/21 - 10:44 pm

GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race

Fierce Biotech

Mon, 06/14/21 - 10:17 am

iTeos Therapeutics

immuno-oncology

GSK reveals 26 million Americans skipped routine vaccinations last year, quantifying widely held suspicions

Fierce Pharma

Fri, 06/11/21 - 12:05 pm

routine vaccinations

AstraZeneca takes PARP battle to court, seeking a larger claim to GSK's key cancer med Zejula: report

Fierce Pharma

Mon, 06/7/21 - 08:45 pm

GlaxoSmithKline scores a big win in Zofran litigation after FDA repeatedly rejects pregnancy warning

Fierce Pharma

Wed, 06/2/21 - 11:04 am

GlaxoSmithKline, under activist pressure, gets some relief as Elliott won't push for sale or slash R&D: report

Fierce Pharma

Thu, 05/27/21 - 11:51 pm

Elliott Management

Sanofi and GSK take COVID-19 vaccine into Phase 3 study

Biopharma Reporter

Thu, 05/27/21 - 11:59 am

clinical trials

FDA authorizes Vir-GSK antibody as variants threaten Eli Lilly mAb

Endpoints

Wed, 05/26/21 - 11:42 pm

Vir Biotechnology

monoclonal antibodies

GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO

Fierce Biotech

Wed, 05/26/21 - 11:16 am

Lyell Immunopharma

Lilly leads the big pharma pack on pipeline value

EP Vantage

Tue, 05/25/21 - 11:04 am

Alzheimer's disease

GlaxoSmithKline's potential proxy brawl with activist Elliott has U.K. officials worried: report

Fierce Pharma

Mon, 05/24/21 - 11:20 pm

A top analyst sees 'inflection point' in the other big vaccine race taking pharma by storm

Endpoints

Mon, 05/24/21 - 11:18 pm

inflection point

Moderna Therapeutics

Bluebird’s new gene therapy among three new EMA OKs ahead of FDA

Endpoints

Fri, 05/21/21 - 10:56 am

monoclonal antibodies

Medicago, GSK’s plant-made COVID jab clears phase 2

Pharmaforum

Tue, 05/18/21 - 11:03 am

clinical trials

Sanofi, GSK say revamped coronavirus vaccine is strong enough for final test

BioPharma Dive

Mon, 05/17/21 - 10:53 am

clinical trials

Merck, GSK and Pfizer vaccines get a boost as CDC lifts two-week restriction on pandemic shots

Fierce Pharma

Thu, 05/13/21 - 11:54 pm

Feds charge another CRO staffer with faking data in a GlaxoSmithKline pediatric asthma study

Endpoints

Wed, 05/12/21 - 11:09 am

Merck, GSK vaccine sales hit by pandemic as competitors' business booms

BioPharma Dive

Thu, 04/29/21 - 10:42 pm

GlaxoSmithKline focuses on split after lacklustre Q1 results

Pharmaforum

Thu, 04/29/21 - 10:41 am

consumer health

Forget the competition. Sanofi still plans to usher its COVID-19 shot across the finish line

Fierce Pharma

Wed, 04/28/21 - 10:49 am

Pages